top of page
Browse by category
Search
RefluxStop provides substantial clinical benefits for GERD patients with marginal budget impact on the health service
Introducing RefluxStop device (Implantica) as a treatment option for gastroesophageal reflux disease (GERD) patients treated within the...
Tirzepatide results in greater weight loss in women than men
All doses of tirzepatide consistently reduced body weight in women and men, but women experienced greater weight loss, according to post...
Semaglutide cardiovascular benefits are maintained in people with impaired kidney function
Semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults...
Large-scale population analysis confirms safety profile of tirzepatide
An analysis of real-world evidence from the FDA Adverse Event Reporting System (FAERS) database of tirzepatide, presented at this year's...
Journal watch 11/09/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Amycretin achieves 13% weight loss within three months with once-a-day tablet
Individuals who received a once-a-day oral weight loss drug, Amycretin developed by Novo Nordisk, lost up to 13% of their body weight...
Browse by tag
bottom of page